JP2022527162A5 - - Google Patents

Info

Publication number
JP2022527162A5
JP2022527162A5 JP2021557247A JP2021557247A JP2022527162A5 JP 2022527162 A5 JP2022527162 A5 JP 2022527162A5 JP 2021557247 A JP2021557247 A JP 2021557247A JP 2021557247 A JP2021557247 A JP 2021557247A JP 2022527162 A5 JP2022527162 A5 JP 2022527162A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
optionally
domain
transmembrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021557247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022527162A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2020/050360 external-priority patent/WO2020194306A1/en
Publication of JP2022527162A publication Critical patent/JP2022527162A/ja
Publication of JP2022527162A5 publication Critical patent/JP2022527162A5/ja
Pending legal-status Critical Current

Links

JP2021557247A 2019-03-26 2020-03-26 Carを発現する遺伝的にリプログラミングされたtreg Pending JP2022527162A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962823711P 2019-03-26 2019-03-26
US62/823,711 2019-03-26
US201962898471P 2019-09-10 2019-09-10
US62/898,471 2019-09-10
PCT/IL2020/050360 WO2020194306A1 (en) 2019-03-26 2020-03-26 Genetically reprogrammed tregs expressing cars

Publications (2)

Publication Number Publication Date
JP2022527162A JP2022527162A (ja) 2022-05-31
JP2022527162A5 true JP2022527162A5 (cg-RX-API-DMAC7.html) 2023-04-03

Family

ID=72610330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021557247A Pending JP2022527162A (ja) 2019-03-26 2020-03-26 Carを発現する遺伝的にリプログラミングされたtreg

Country Status (9)

Country Link
US (1) US20220186232A1 (cg-RX-API-DMAC7.html)
EP (1) EP3947690A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022527162A (cg-RX-API-DMAC7.html)
KR (1) KR20210143856A (cg-RX-API-DMAC7.html)
CN (1) CN114127297A (cg-RX-API-DMAC7.html)
AU (1) AU2020245329A1 (cg-RX-API-DMAC7.html)
CA (1) CA3134878A1 (cg-RX-API-DMAC7.html)
IL (1) IL286644A (cg-RX-API-DMAC7.html)
WO (1) WO2020194306A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7493497B2 (ja) * 2018-06-19 2024-05-31 フォンダッツィオーネ・テレソン・エティエッセ 操作された樹状細胞の生産及びその使用
CA3206885A1 (en) * 2021-02-02 2022-08-11 Carisma Therapeutics Inc. Self-polarizing immune cells
CA3228536A1 (en) * 2021-08-24 2023-03-02 Yugang Guo Il-10 expressing cells for enhanced cancer immunotherapies
EP4444361A4 (en) * 2021-12-09 2025-12-10 Carisma Therapeutics Inc IN VIVO ADMINISTRATION TO IMMUNE CELLS
JP2025503546A (ja) * 2021-12-30 2025-02-04 ティーアール1エックス,インコーポレーテッド Il-10およびキメラ抗原受容体を発現するcd4+t細胞およびその使用
EP4565702A4 (en) * 2022-08-03 2026-08-05 Migal Galilee Research Inst Ltd Chimeric membrane-bound cytokines incorporating co-stimulatory elements to enhance anti-inflammatory function
CN117402257B (zh) * 2023-09-13 2025-08-26 武汉大学 人工病毒受体及其应用
CN122555725A (zh) * 2024-01-08 2026-08-11 上药生物治疗(香港)有限公司 膜表达il-10及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596769A (en) * 1984-03-05 1986-06-24 Temple University Monoclonal antibodies to peptidoglycan and methods of preparing same
AU5275100A (en) * 1999-05-21 2000-12-12 Regents Of The University Of California, The Fluorescent protein indicators
JP2003533542A (ja) * 2000-05-24 2003-11-11 セル−サイ・コーポレーシヨン T細胞結合リガンド、それを含むペプチド構築物およびそれらの免疫障害を処置するための使用
WO2003106616A2 (en) * 2002-06-12 2003-12-24 Gavish-Galilee Bio Applications Ltd MEMBRANE-ANCHORED β2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
WO2011021524A1 (ja) * 2009-08-19 2011-02-24 国立大学法人名古屋大学 乳酸菌の付着性を誘導するペプチド及びその用途
EP2934532B1 (en) * 2012-12-20 2019-10-23 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
GB201317929D0 (en) * 2013-10-10 2013-11-27 Ucl Business Plc Chimeric antigen receptor
CN107207613B (zh) * 2015-08-07 2020-06-09 深圳市体内生物医药科技有限公司 含Toll样受体胞内结构域的嵌合抗原受体
US11365391B2 (en) * 2015-09-28 2022-06-21 Trustees Of Dartmouth College Chimeric antigen receptor anti-inflammatory cells and methods of use
CA3020993A1 (en) * 2016-04-14 2017-10-19 Bluebird Bio, Inc. Salvage chimeric antigen receptor systems
MX2019003462A (es) * 2016-09-28 2019-08-16 Gavish Galilee Bio Appl Ltd Una plataforma universal para el tratamiento con car que se dirige a una novedosa firma antigenica del cancer.
CA3072859A1 (en) * 2017-08-23 2019-02-28 Max-Delbruck-Centrum Fur Molekulare Medizin In Der Helmholtz-Gemeinscht Chimeric antigen receptor and car-t cells that bind cxcr5
AU2019240370B2 (en) * 2018-03-23 2024-03-07 Gavish-Galilee Bio Applications Ltd. Genetically reprogrammed Tregs expressing membrane-bound IL-10

Similar Documents

Publication Publication Date Title
KR102646495B1 (ko) 재조합 pMHC II형 분자
US20240383965A1 (en) Compositions and methods of phospholipase a2 receptor chimeric autoantibody receptor t cells
KR102488477B1 (ko) 신속하고 포괄적인 t-세포 면역 모니터링을 위한 세포 플랫폼
US20250074960A1 (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
Lanier Activating and inhibitory NK cell receptors
JP5736368B2 (ja) 少なくとも2つのα3ドメインを含むHLA−Gの多量体ポリペプチド及び医薬としてのその使用
JP2023036657A (ja) 修飾されたt細胞及びその使用方法
JP2021519107A5 (cg-RX-API-DMAC7.html)
JP2023520205A5 (cg-RX-API-DMAC7.html)
CN107074929A (zh) 嵌合自身抗体受体t细胞的组合物和方法
EA035931B1 (ru) Связывающиеся с эритроцитами терапевтические средства
RU2020109577A (ru) Клетка
MX2007014919A (es) Receptores de celulas t de melan-a de alta afinidad.
JP2019513394A (ja) キメラアロ抗原受容体t細胞の組成物および方法
CN111819186A (zh) 表达嵌合抗原受体的免疫细胞
WO2020018691A1 (en) Modified t cells and methods of their use
JP2022527813A (ja) Magea1特異的t細胞受容体およびその使用
US20080292602A1 (en) T Cell Receptors Which Specifically Bind to Vygfvracl-Hla-A24
WO2023010118A1 (en) Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same
EP2264067A1 (en) HLA-G alpha 1 multimers and pharmaceutical uses thereof
US20250073265A1 (en) Compositions and Methods of Chimeric Autoantibody Receptor Cells Expressing Extended Phospholipase A2 Receptor Fragments
US20090208502A1 (en) Apoptosis-inducing protein complexes and therapeutic use thereof
Radosavljevic et al. In vivo immunogenetics: from MIC to RAET1 loci
Moretta et al. Function and specificity of human natural killer cell receptors
Richardson et al. Definition of polymorphic residues on killer Ig‐like receptor proteins which contribute to the HLA‐C binding site